Brief: Lucira Covid-19 Test Kit Identifies Viral Variants
April 9 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA COVID-19 TEST KIT IDENTIFIES VIRAL VARIANTS
* LUCIRA HEALTH - CONFIRMED IT CAN IDENTIFY "DOUBLE MUTANT"
VARIANT OF COVID-19 WITH ITS LUCIRA MOLECULAR TEST KIT
Source text for Eikon: ID:nBw1czf63a
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process